A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)
Clinical trial NCT02692703 · COMPLETED
Trial details
- NCT number
- NCT02692703
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-22
- Primary completion
- 2017-04-13
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.